A. Kallioniemi et al., IDENTIFICATION OF GAINS AND LOSSES OF DNA-SEQUENCES IN PRIMARY BLADDER-CANCER BY COMPARATIVE GENOMIC HYBRIDIZATION, Genes, chromosomes & cancer, 12(3), 1995, pp. 213-219
Comparative genomic hybridization (CGH) makes it possible to detect lo
sses and gains of DNA sequences along all chromosomes in a tumor speci
men based on the hybridization of differentially labeled tumor and nor
mal DNA to normal human metaphase chromosomes. In this study, CGH anal
ysis was applied to the identification of genomic imbalances in 26 bla
dder cancers in order to gain information on the genetic events underl
ying the development and progression of this malignancy. Losses affect
ing 11p, 11q, 8p, 9, 17p, 3p, and 12q were all seen in more than 20% o
f the tumors. The minimal common region of loss in each chromosome was
identified based on the analysis of overlapping deletions in differen
t tumors. Gains of DNA sequences were most often found at chromosomal
regions distinct from the locations of currently known oncogenes. The
bands involved in more than 10% of the tumors were 8q21, 13q21-q34, 1q
31, 3q24-q26, and 1p22. in conclusion, these CGH data highlight severa
l previously unreported genetic alterations in bladder cancer. Further
detailed studies of these regions with specific molecular genetic tec
hniques may lead to the identification of tumor suppressor genes and o
ncogenes that play an important role in bladder tumorigenesis. (C) 199
5 Wiley-Liss, Inc.